Literature DB >> 8286696

Contraception choice and sexually transmitted disease.

K T Barnhart1, S J Sondheimer.   

Abstract

Sexually active couples need to be concerned with the risk of sexually transmitted diseases (STDs) and how their choice of contraception influences that risk. Condoms provide the best documented protection against such pathogens as: gonorrhea, herpes simplex virus (HSV), hepatitis B, HIV, and chlamydia. Female dependent barrier methods also provide protection against most STDs and also possibly HIV. Most hormonal non-barrier contraceptives, although providing excellent protection against unwanted pregnancies, provide little protection against STDs. Oral contraceptive pills (OCP) may increase the risk of infection with human papillomavirus (HPV) and cervical infections of chlamydia. Individuals at high risk for both an unwanted pregnancy and an STD should be counseled to use both a hormonal and barrier contraceptive. Recently, nonoxynol-9 (N-9) and OCP use have been associated with an increase in HIV infection in African women at high risk for HIV. This association has not been found in other studies and currently does not outweigh the proven benefits of these contraceptive methods.

Entities:  

Keywords:  Barrier Methods; Behavior; Condom; Contraception; Contraceptive Methods; Contraceptive Methods Chosen; Contraceptive Usage; Decision Making; Diseases; Family Planning; Infections; Literature Review; Oral Contraceptives; Reproductive Tract Infections; Sexually Transmitted Diseases--prevention and control; Vaginal Barrier Methods

Mesh:

Year:  1993        PMID: 8286696

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  3 in total

1.  Human Papillomavirus: Confronting the Epidemic-A Urologist's Perspective.

Authors:  Richard A Watson
Journal:  Rev Urol       Date:  2005

2.  High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional study.

Authors:  Miao Li; Qing-Fan Yang; Qian Cao; Jian Tang; Yu Gao; Min Zhi; Kang Chao; Ming-Li Su; Wei-Min Huang; Yan Yi; Sui-Yan Xia; Ling-Jie Huang; Yuan Zhao; Xiao-Hong Wang; Xiao-Ying Liu; Lin Lin; Pin-Jin Hu; Xiang Gao
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-02-15

3.  An economic analysis of premarriage prevention of hepatitis B transmission in Iran.

Authors:  Peyman Adibi; Mohammadreza Rezailashkajani; Delnaz Roshandel; Negar Behrouz; Shahin Ansari; Mohammad Hossein Somi; Saeed Shahraz; Mohammad Reza Zali
Journal:  BMC Infect Dis       Date:  2004-09-04       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.